Nicorandil as a hybrid between nitrates and potassium channel activators

https://doi.org/10.1016/0002-9149(89)90200-2Get rights and content

Abstract

Nicorandil, although structurally a nitrate, differs from classic nitrates in several respects. It preferentially dilates resistive vessels. Its effect on venous return in dogs is not unanimously a decrease but rather an increase. In high doses or concentrations it suppresses myocardial contraction and ventricular automaticity, nearly sparing sinoatrial nodal automaticity and atrioventricular nodal conduction. It shortens the effective refractory period of myocardium. These cardiac effects of nicorandil have been explained by its mechanism of action as a potassium (K) channel activator. However, what part of the vascular effects of nicorandil this mechanism is responsible for has not been determined. BRL 34915 and pinacidil, nonnitrate vasodilators with a K-channel activator action, have essentially the same cardiovascular profile as nicorandil in isolated, blood-perfused canine heart preparations. In anesthetized, open-chest dogs the 2 K-channel activators decreased systemic blood pressure and increased venous return and cardiac output without elevating heart rate, unless the cardiodepressant effect emerged. The increase in venous return or cardiac output survived elimination of baroceptor functions. These results taken together with previous results on nicorandil suggest the following: (1) The property of nicorandil as a resistive vessel dilator highly selective for vasculature originates in its mechanism of action as a K-channel activator. The nonunanimous effect of nicorandil on venous return is a result of the opposing actions as a capacitive (action as a nitrate) and a resistive vessel dilator. Nicorandil, with its hybrid nature, is advantageous over specific K-channel activators and classic nitrates in therapeutic implications.

References (38)

  • RE Buckingham et al.

    BRL 34915, a novel antihypertensive agent: Comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models

    J Cardiovasc Pharmacol

    (1986)
  • N Taira

    Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview

    J Cardiovasc Pharmacol

    (1987)
  • M Endoh et al.

    Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery

    Naunyn Schmiedebergs Arch

    (1983)
  • S Holzmann

    Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75)

    J Cardiovasc Pharmacol

    (1983)
  • M Endoh et al.

    Effects of nicorandil and its interaction with isoproterenol on force of contraction and cyclic nucleotide levels of canine atrial muscle: Comparison with carbachol

    J Cardiovasc Pharmacol

    (1983)
  • T Yanagisawa et al.

    Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75)

    Jpn J Pharmacol

    (1979)
  • T Yanagisawa et al.

    Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibers of the dog. Increase in potassium conductance

    Naunyn Schmiedebergs Arch Pharmacol

    (1980)
  • T Yanagisawa et al.

    Effect of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers

    Jpn J Pharmacol

    (1981)
  • S Imanishi et al.

    Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: Possible increase in potassium conductance

    J Pharmacol Exp Ther

    (1983)
  • K Furukawa et al.

    Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries

    J Pharmacol Exp Ther

    (1981)
  • T Itoh et al.

    Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries

    J Pharmacol Exp Ther

    (1981)
  • T Karashima et al.

    Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells of the guinea-pig mesenteric and portal veins

    J Pharmacol Exp Ther

    (1982)
  • T Inoue et al.

    Effects of 2-nicotinamidoethyl nitrate (nicorandil; SG-75) and its derivatives on smooth muscle cells of the canine mesenteric artery

    J Pharmacol Exp Ther

    (1984)
  • Taira N, Satoh K, Yanagisawa T, Imai Y, Hiwatari M. Pharmacological profile of a new coronary vasodilator drug,...
  • N Taira

    Differences in cardiovascular profile among calcium antagonists

    Am J Cardiol

    (1987)
  • WR Kukovetz et al.

    Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle

    Nauyn Schmiedebergs Arch Pharmacol

    (1979)
  • KL Axelsson et al.

    Correlation between vascular smooth muscle relaxation and increase in cyclic GMP induced by some organic nitro esters

    Acta Pharmacol Toxicol

    (1981)
  • Y Takata et al.

    ATP-induced hyperpolarization of smooth muscle cells of the guinea-pig coronary artery

    J Pharmacol Exp Ther

    (1980)
  • Y Uchida et al.

    Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation

    Jpn Heart J

    (1978)
    Y Uchida et al.

    Clin Exp Pharmacol Physiol

    (1979)
  • Cited by (325)

    View all citing articles on Scopus
    View full text